135 related articles for article (PubMed ID: 38282808)
1. Liquid-Based Cervical Cytology: Monitoring the Laboratory Quality Indicators.
Nayak SS; Dutta A; Khedkar R; Roy S
J Cytol; 2024; 41(1):1-7. PubMed ID: 38282808
[TBL] [Abstract][Full Text] [Related]
2. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
Latsuzbaia A; Hebette G; Fischer M; Arbyn M; Weyers S; Vielh P; Schmitt F; Mossong J
Diagn Cytopathol; 2017 May; 45(5):384-390. PubMed ID: 28247516
[TBL] [Abstract][Full Text] [Related]
3. Bethesda system reporting rates, histological follow-up and HPV genotypes distribution of abnormal cytology in Anhui province of China: Analysis of 93,168 cervical liquid-based cytology test reports.
Xu H; Chen Y; Zhao C; Wang Q; Tang M; Zhang W; Wang Q; Lou R; Liu T; Feng Y; Zhang H
Diagn Cytopathol; 2023 Aug; 51(8):501-510. PubMed ID: 37114437
[TBL] [Abstract][Full Text] [Related]
4. Significance of high-risk human papillomavirus DNA detection in women 50 years and older with squamous cell papanicolaou test abnormalities.
Zhao C; Zhao S; Heider A; Austin RM
Arch Pathol Lab Med; 2010 Aug; 134(8):1130-5. PubMed ID: 20670132
[TBL] [Abstract][Full Text] [Related]
5. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
Juric D; Mahovlić V; Rajhvajn S; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Projić IS; Babić D; Susa M; Corusić A; Oresković S
Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728
[TBL] [Abstract][Full Text] [Related]
6. Role of Cervical Cancer Biomarkers p16 and Ki67 in Abnormal Cervical Cytological Smear.
Gothwal M; Nalwa A; Singh P; Yadav G; Bhati M; Samriya N
J Obstet Gynaecol India; 2021 Feb; 71(1):72-77. PubMed ID: 33814802
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the Performance of p16
Song F; Du H; Xiao A; Wang C; Huang X; Yan P; Liu Z; Qu X; Belinson JL; Wu R
Cancer Manag Res; 2020; 12():9067-9075. PubMed ID: 33061601
[TBL] [Abstract][Full Text] [Related]
8. Quality metrics in cervical cytopathology: A single institutional study.
Senthil Kumar D; Ravikumar G
Cytopathology; 2022 Mar; 33(2):230-235. PubMed ID: 34854153
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].
Luo HX; Du H; Liu ZH; Zhang LJ; Wang C; Wu RF
Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):232-238. PubMed ID: 29575846
[No Abstract] [Full Text] [Related]
10. Liquid-based cytology and human papillomavirus testing: a pooled analysis using the data from 13 population-based cervical cancer screening studies from China.
Pan QJ; Hu SY; Guo HQ; Zhang WH; Zhang X; Chen W; Cao J; Jiang Y; Zhao FH; Qiao YL
Gynecol Oncol; 2014 May; 133(2):172-9. PubMed ID: 24631450
[TBL] [Abstract][Full Text] [Related]
11. Liquid-based cytology: do ancillary techniques enhance detection of epithelial abnormalities?
Mishra S; Husain N; Awasthi NP; Pradeep Y; Roohi R; Saxena S
Arch Gynecol Obstet; 2018 Jul; 298(1):159-169. PubMed ID: 29728850
[TBL] [Abstract][Full Text] [Related]
12. [Health technology assessment report. Use of liquid-based cytology for cervical cancer precursors screening].
Ronco G; Confortini M; Maccallini V; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Giorgi Rossi P
Epidemiol Prev; 2012; 36(5 Suppl 2):e1-e33. PubMed ID: 23139163
[TBL] [Abstract][Full Text] [Related]
13. Cytology and high risk HPV testing in cervical cancer screening program: Outcome of 3-year follow-up in an academic institute.
Yang J; Nolte FS; Chajewski OS; Lindsey KG; Houser PM; Pellicier J; Wang Q; Ehsani L
Diagn Cytopathol; 2018 Jan; 46(1):22-27. PubMed ID: 29048733
[TBL] [Abstract][Full Text] [Related]
14. Implementation of the ThinPrep Imaging System in a tertiary military medical center.
Duby JM; DiFurio MJ
Cancer; 2009 Aug; 117(4):264-70. PubMed ID: 19536887
[TBL] [Abstract][Full Text] [Related]
15. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
[TBL] [Abstract][Full Text] [Related]
16. Cervical Cytology and Histology Correlation as an Analytic Quality Assurance Exercise: Experience from an Accredited Cytology Laboratory.
Belekar SV; Kamal M; Warke AS
J Cytol; 2023; 40(4):205-210. PubMed ID: 38058668
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Performance of CinTec® PLUS in SurePathTM Liquid-Based Cervico-Vaginal Samples.
Sharma P; Gupta P; Gupta N; Suri V; Rajwanshi A
Turk Patoloji Derg; 2021; 37(1):32-38. PubMed ID: 33372263
[TBL] [Abstract][Full Text] [Related]
18. Proposed Sheffield quantitative criteria in cervical cytology to assist the diagnosis and grading of squamous intra-epithelial lesions, as some Bethesda system definitions require amendment.
Slater DN; Rice S; Stewart R; Melling SE; Hewer EM; Smith JH
Cytopathology; 2005 Aug; 16(4):168-78. PubMed ID: 16048503
[TBL] [Abstract][Full Text] [Related]
19. Cervical cytology of atypical squamous cells, cannot exclude high-grade squamous intra-epithelial lesion: significance of age, human papillomavirus DNA detection and previous abnormal cytology on follow-up outcomes.
Sung CO; Oh YL; Song SY
Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):155-9. PubMed ID: 21683502
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
